Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Study on Production of Antibody in Milk Immunized Cows with Some Helicobacter pylori Antigen

Helicobacter pylori 항원을 이용한 면역우유 생산에 관한 연구

  • Park, Chang-Ho (Dept. of Oriental Medicine Biofood Science, Daegu Haany University) ;
  • Kim, Soo-Jung (Dept. of Oriental Medicine Biofood Science, Daegu Haany University) ;
  • Yea, Eon-Ju (Dept. of Oriental Medicine Biofood Science, Daegu Haany University) ;
  • Bae, Man-Jong (Dept. of Oriental Medicine Biofood Science, Daegu Haany University)
  • 박창호 (대구한의대학교 한방바이오식품과학과) ;
  • 김수정 (대구한의대학교 한방바이오식품과학과) ;
  • 예은주 (대구한의대학교 한방바이오식품과학과) ;
  • 배만종 (대구한의대학교 한방바이오식품과학과)
  • Published : 2005.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study has been to produce of anti-H. pylori antibody in milk produced from cows immunized with antigen of Helicobacter pylori and to search the relationship between vaccine dosage and antibody formation and impact of vaccine dosage on cows. The content of anti-H. pylori antibody in serum and whey increased in accordance with vaccine dosage volume. It has been confirmed that the formation of high-quantified antibody was produced in all groups with vaccine dosages of 10 mL, 20 mL and 30 mL. It has been turned out that the antibody was formed most in 20 mL dosage. It was inclined to $12\%$ reduce caused by vaccine injection, but recovered after about maximum 1 week. In measurement of body temperature of cows after vaccine injected, it was inclined to rise with the normal scope in comparison with the controlled conditions.

본 연구는 위염, 위궤양, 위림프종 및 위암과 같은 소화기 질환의 원인균으로 알려진 Helicobacter pylori균을 항원으로 하여 젖소에 면역시킨 후 생산된 우유의 anti-H. pylori 항체 생성능을 검토하고, 백신 투여량과 항체 생성과의 관계, 비유시기에 따른 항체생성과의 관계 그리고 백신투여가 젖소에 미치는 영향을 알아보았다. 백신 투여량에 따른 혈청과 유청내의 anti-H. pylori항체의 함량은 10 mL, 20 mL, 30 mL 백신투여 모든 군에서 대조구에 비해서 높은 항체 생성량을 확인하였으며, 그 중 20 mL 투여가 항체 생성에 가장 큰 영향을 미친 것으로 조사되었다. 백신 투여량에 따른 유청내의 antl-H. pylori항체 생성량은 혈청에서 나타난 결과와 유사한 결과를 나타내었다. 백신투여에 따른 비유시기별 항체함량은 혈액내에서는 $2\~4$주까지 증가하는 경향을 보이다가 $6\~12$주 사이에는 대조구와 유의성 있는 차이를 보였고, 처리구간 항체생성량은 비유초기>비유중기>비유 후기 순으로 유의성있는 차이를 나타내었다(p<0.05). 그리고 유청내 항체 함량은 혈액과 유사한 경향을 나타내며 항체함량이 증가하였으나, 처리구간의 유의적인 차이는 나타나지 않았다. 백신투여로 인하여 백신투여 1일째의 산유량은 $12\%$ 감소하는 경향을 나타냈고, 최장 1주일 정도 지나면서 회복되었다. 백신투여 후 젖소의 체온을 측정한 결과 정상적인 범위 내에서 체온이 상승하여 백신투여가 젖소의 생리적 변화에 큰 영향을 미치지 않는 것으로 나타났다.

Keywords

References

  1. Marshall BJ, Warren JR. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 323: 1311-1315 https://doi.org/10.1016/S0140-6736(84)91816-6
  2. Warren JR, Marshall B. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 321: 1273-1275 https://doi.org/10.1016/S0140-6736(83)92719-8
  3. Hunt RH. 1996. Eradication of Helicobacter pylori infection. Am J Med 100(5A): 42S-50S https://doi.org/10.1016/S0002-9343(96)80228-2
  4. Satoh K, Kimura K, Taniguchi Y, Yoshida Y, Kihira K, Takimoto T, Kawata H, Saifuku K, Ido K, Takemoto T, Ota Y, Tada M, Karita M, Sakaki N, Hoshihara Y. 1996. Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am J Gastroenterol 91: 963-969
  5. Early EM, Hardy H, Forde T, Kane M. 2001. Bactericidal effect of a whey protein concentrate with anti - Helicobacter pylori activity. J Appl Microbiol 90: 741-748 https://doi.org/10.1046/j.1365-2672.2001.01301.x
  6. Brussow H, Hilpert H, Walther I, Sidoti J, Mietens C, Bachmann P. 1987. Bovine milk immunoglobulins for passive immunity to infantile Rotavirus gastroenteritis. J Clin Microbiol 25: 982-986
  7. Mulcahy G, O'Connor F, McGonigle S, Dowd A, Clery DG, Andrews SJ, Dalton JP. 1998. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine 16: 932-939 https://doi.org/10.1016/S0264-410X(97)00289-2
  8. Blaser MJ. 1997. Not all Helicobater pylori strains are created equal: should all be eliminated? Lancet 349: 1020-1022 https://doi.org/10.1016/S0140-6736(96)09133-7
  9. Blaser MJ. 1999. Hupothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. Infect Dis 179: 1523-1530 https://doi.org/10.1086/314785
  10. Moss S, Clam J. 1992. Helicobacter pylori and peptic ulcers: the present position. Gut 32: 289-292
  11. Graham DY, Opekun AR, Klein PD. 1993. Clarithromycin for the eradication of Helicobater pylori. J Clin Gastroenterol 16: 292-294 https://doi.org/10.1097/00004836-199306000-00004
  12. Haller D, Bode CH, Hammes WP, Pfeifer AMA, Schiffrin E, Blum S. 2000. Nonpathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte cocultures. Gut 47: 79-87 https://doi.org/10.1136/gut.47.1.79
  13. Blaser MJ. 1990. Helicobacter pylori and the pathogenesis of gastroduodenal inflamation. J Infect Dis 161: 626-633 https://doi.org/10.1093/infdis/161.4.626
  14. Logan RP, Polson RJ, Misiewicz JJ, Rao G, Karim NQ, Newell D, Johnson P, Wadsworth J, Walker MM, Baron JH. 1991. Simplified single sample 13 carborn urea breath test for Helicobater pylori; comparison with histology, culture, and ELISA serology. Gut 32: 1461-1464 https://doi.org/10.1136/gut.32.12.1461
  15. Tacket CO, Losonsky G, Link H, Hoang Y, Guesry P, Hilpert H, Levine MM. 1988. Protection by milk immunoglobulin concentrate against oral challenger with enterotoxigenic Esherichia coli. N Engl J Med 318: 1240-1243 https://doi.org/10.1056/NEJM198805123181904
  16. Tomita GM, Todhunter DA, Hogan JS, Smith KL. 1995. Immunization of dairy cows with an Escherichia coil J5 lipopolysaccharide vaccine. J Dairy Sci 78: 2178-2185 https://doi.org/10.3168/jds.S0022-0302(95)76845-X
  17. 김현욱. 1998. 낙농화학. 선진문화사, 서울. p 84-106
  18. 김영교, 김영주, 김현욱. 2000. 우유와 유제품의 과학. 선진문화사, 서울. p 35-57